secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zura Bio Ltd (ZURA)
CIK:        0001855644
Form:       8-K
Filed at:   2023-01-19T23:59:59+00:00
Accession:  0001104659-23-005068
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 1.01, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

JATT shareholders approve extension but 87.8% of public shares redeemed, trust drops to ~$17.3M
--------------------------------------------------------------------------------

- Shareholders approved extension of business combination deadline to April 17, 2023.
- 12,111,022 Class A shares redeemed at $10.257 per share (~$124.2M total), 87.76% of outstanding.
- Trust account reduced to ~$17.3M plus $101,338 sponsor contribution for the extension.
- Sponsor contributed $101,338 in exchange for an unsecured promissory note repayable upon closing.
- Third Amendment to BCA executed January 13, 2023, extending Outside Date to April 17, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855644/000110465923005068/0001104659-23-005068-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855644/000110465923005068/tm233516d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-005068

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer